All the medical practitioners that are working in the 21st century dream that this is the time they will manage to beat cancer once and for all. To try and make this dream a reality, there are many steps that they have put in place including the inclusion of technology in cancer research. The Tempus Initiative, which is the brainchild of Eric Lefkosky, is an attempt to make sure that through the use of technology, the quality of care that is given to people that suffer from cancer.
Eric has always been a stronger believer in the fact that the best way to deal with cancer and any of the other progressive illnesses was through genetic sequencing. He believes that when technology is used to track the progress of cancer patients, it will be possible to tell how they will react to certain treatments and to even predict complications even before they occur and look for solutions to them.
He started his journey towards becoming the successful entrepreneur that he is when he was in college. When he was studying law at the University of Michigan, he started a company that was meant to supply upholstery and named it Brandon Apparel. They had gotten the capital they needed to create the business from their close family and friends and more information click here.
The second business that he started came to be known as Innerworkings. It was known as Innerworkings and provided procurement to SMEs. The company held its first IPO in 2012 after growing successfully. At the time when he was still growing this business, he got the idea to start a third business, which he did and named it Echo Global Statistics. The company has its stocks listed on NASDAQ .
These are applications that are used by the Doctors and other medical practitioners
together with their patients. Using the applications, the Doctors are able to know the treatments that will work and eliminate those that will not work as they should. When it comes to philanthropy, Lefkosky is a member of the board of the Chicago children’s hospital.